European Patent Office Intends To Grant Savara Patent For Liquid Formulation Of MOLBREEVI
Benzinga Newsdesk 10 months ago
NewsLegal
-- Once Granted, the Patent Will Provide Protection for MOLBREEVI in Europe Until March 2041 ---- Savara Was Also Recently Granted a European Patent Covering the Investigational Drug-Device Combination of MOLBREEVI
-- Once Granted, the Patent Will Provide Protection for MOLBREEVI in Europe Until March 2041 --
-- Savara Was Also Recently Granted a European Patent Covering the Investigational Drug-Device Combination of MOLBREEVI Delivered Via PARI's Proprietary eFlow® Nebulizer System --